An Aγ-globin G->A gene polymorphism associated with β039 thalassemia globin gene and high fetal hemoglobin production
Tóm tắt
Từ khóa
Tài liệu tham khảo
Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet. 2001;2:245–55.
Weatherall DJ. Pathophysiology of thalassaemia. Baillieres Best Pract Res Clin Haematol. 1998;11:127–46.
Giardine B, Borg J, Viennas E, Pavlidis C, Moradkhani K, Joly P, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–9.
Atweh G, Fathallah HV. Pharmacologic induction of fetal hemoglobin production. Hematol Oncol Clin North Am. 2010;24:1131–44.
Gambari R, Fibach E. Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia. Curr Med Chem. 2007;14:199–212.
Finotti A, Gambari R. Recent trends for novel options in experimental biological therapy of β-thalassemia. Expert Opin Biol Ther. 2014;14:1443–54.
Gambari R. Alternative options for DNA-based experimental therapy of β-thalassemia. Expert Opin Biol Ther. 2012;12:443–62.
Fibach E, Bianchi N, Borgatti M, Prus E, Gambari R. Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood. 2003;102:1276–81.
Fibach E, Bianchi N, Borgatti M, Zuccato C, Finotti A, Lampronti I, et al. Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients. Eur J Haematol. 2006;77:437–41.
Perrine SP, Pace BS, Faller DV. Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies. Hematol Oncol Clin North Am. 2014;28:233–48.
Lampronti I, Bianchi N, Zuccato C, Dall'acqua F, Vedaldi D, Viola G, et al. Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs. Int J Hematol. 2009;90:318–27.
Bianchi N, Cosenza LC, Lampronti I, Finotti A, Breveglieri G, Zuccato C, et al. Structural and functional insights on an uncharacterized Aγ-Globin-gene polymorphism present in four β0-Thalassemia families with high fetal hemoglobin levels. Mol Diagn Ther. 2016;20:161–73.
Thein SL. The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. Blood Rev. 2012;26(Suppl 1):S35–9.
Thein SL, Menzel S, Lathrop M, Garner C. Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum Mol Genet. 2009;18(R2):R216–23.
Nguyen TK, Joly P, Bardel C, Moulsma M, Bonello-Palot N, Francina A. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients. Blood Cells Mol Dis. 2010;45:124–7.
Trakarnsanga K, Wilson MC, Lau W, Singleton BK, Parsons SF, Sakuntanaga P, et al. Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL. Haematologica. 2014;99:1677–85.
Danjou F, Francavilla M, Anni F, Satta S, Demartis FR, Perseu L, et al. A genetic score for the prediction of beta-thalassemia severity. Haematologica. 2015;100:452–7.
Badens C, Joly P, Agouti I, Thuret I, Gonnet K, Fattoum S, et al. Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease. Haematologica. 2011;96:1712–4.
Banan M, Bayat H, Azarkeivan A, Mohammadparast S, Kamali K, Farashi S. The XmnI and BCL11A single nucleotide polymorphisms may help predict hydroxyurea response in Iranian β-thalassemia patients. Hemoglobin. 2012;36:371–80.
Ju J, Wang Y, Liu R, Zhang Y, Xu Z, Wang Y, et al. Human fetal globin gene expression is regulated by LYAR. Nucleic Acids Res. 2014;42:9740–52.
Kerdpoo S, Limweeraprajak E, Tatu T. Effect of Swiss-type heterocellular HPFH from XmnI-Gγ and HBBP1 polymorphisms on HbF, HbE, MCV and MCH levels in Thai HbE carriers. Int J Hematol. 2014;99:338–44.
Roy P, Bhattacharya G, Mandal A, Dasgupta UB, Banerjee D, Chandra S, et al. Influence of BCL11A, HBS1L-MYB, HBBP1 single nucleotide polymorphisms and the HBG2 XmnI polymorphism On Hb F levels. Hemoglobin. 2012;36:592–9.
Fibach E, Manor D, Oppenheim A, Rachmilewitz EA. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood. 1989;73:100–3.
Fibach E, Kollia P, Schechter AN, Noguchi CT, Rodgers GP. Hemin-induced acceleration of hemoglobin production in immature cultured erythroid cells: preferential enhancement of fetal hemoglobin. Blood. 1995;85:2967–74.
Bianchi N, Finotti A, Ferracin M, Zuccato C, Breveglieri G, Brognara E, et al. Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of Rapamycin regulated proteins following Mithramycin treatment of human Erythroid cells. PLoS One. 2015;10:e6121567.
Finotti A, Bianchi N, Fabbri E, Borgatti M, Breveglieri G, Gasparello J, et al. Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions. Pharmacol Res. 2015;91:57–68.
Coleman MB, Steinberg MH, Adams JG. A four-base deletion 5′ to the Aγ-globin gene is a common polymorphism. Blood. 1991;78:2473–4.
Cosenza LC, Breda L, Breveglieri G, Zuccato C, Finotti A, Lampronti I, et al. A validated cellular biobank for β-thalassemia. J Transl Med. 2016;14:255–65.
Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, Van Handel B, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322:1839–42.
Sankaran VG. Targeted therapeutic strategies for fetal hemoglobin induction. Hematology Am Soc Hematol Educ Program. 2011;2011:459–65.
Motovali-Bashi M, Ghasemi T. Role of XmnIgG polymorphism in Hydroxyurea treatment and fetal hemoglobin level at Isfahanian intermediate β-Thalassemia patients. Iran Biomed J. 2015;19:177–82.